Hong Kong
· Delayed Price · Currency is HKD HUTCHMED (China) Statistics
Total Valuation
HUTCHMED (China) has a market cap or net worth of HKD 20.30 billion. The enterprise value is 14.93 billion.
| Market Cap | 20.30B |
| Enterprise Value | 14.93B |
Important Dates
The next estimated earnings date is Wednesday, March 5, 2025.
| Earnings Date | Mar 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.97% |
| Shares Change (QoQ) | +0.13% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 516.07M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 3.51 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -45.56 |
| EV / Sales | 3.20 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -29.27 |
Financial Position
The company has a current ratio of 2.81, with a Debt / Equity ratio of 0.12.
| Current Ratio | 2.81 |
| Quick Ratio | 2.66 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.36 |
| Interest Coverage | -159.16 |
Financial Efficiency
Return on equity (ROE) is -5.44% and return on invested capital (ROIC) is -8.98%.
| Return on Equity (ROE) | -5.44% |
| Return on Assets (ROA) | -5.90% |
| Return on Capital (ROIC) | -8.98% |
| Revenue Per Employee | 2.42M |
| Profits Per Employee | -166,352 |
| Employee Count | 1,988 |
| Asset Turnover | 0.48 |
| Inventory Turnover | 13.12 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -17.29% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -17.29% |
| 50-Day Moving Average | 26.82 |
| 200-Day Moving Average | 28.52 |
| Relative Strength Index (RSI) | 38.15 |
| Average Volume (20 Days) | 5,263,473 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HUTCHMED (China) had revenue of HKD 4.77 billion and -327.71 million in losses. Loss per share was -0.38.
| Revenue | 4.77B |
| Gross Profit | -370.53M |
| Operating Income | -943.24M |
| Pretax Income | -293.15M |
| Net Income | -327.71M |
| EBITDA | -860.10M |
| EBIT | -943.24M |
| Loss Per Share | -0.38 |
Balance Sheet
The company has 6.27 billion in cash and 691.76 million in debt, giving a net cash position of 5.58 billion.
| Cash & Cash Equivalents | 6.27B |
| Total Debt | 691.76M |
| Net Cash | 5.58B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 5.87B |
| Book Value Per Share | 6.76 |
| Working Capital | 5.27B |
Cash Flow
In the last 12 months, operating cash flow was -366.81 million and capital expenditures -143.37 million, giving a free cash flow of -510.18 million.
| Operating Cash Flow | -366.81M |
| Capital Expenditures | -143.37M |
| Free Cash Flow | -510.18M |
| FCF Per Share | n/a |
Margins
Gross margin is -7.77%, with operating and profit margins of -19.78% and -6.87%.
| Gross Margin | -7.77% |
| Operating Margin | -19.78% |
| Pretax Margin | -6.15% |
| Profit Margin | -6.87% |
| EBITDA Margin | -18.03% |
| EBIT Margin | -19.78% |
| FCF Margin | n/a |
Dividends & Yields
HUTCHMED (China) does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.97% |
| Shareholder Yield | -0.97% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HUTCHMED (China) has an Altman Z-Score of 3.2.
| Altman Z-Score | 3.2 |
| Piotroski F-Score | n/a |